Home
Search

News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
Browse All
"Build Back Better Act" Drug Pricing Provisions…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after the House of Representatives passed the Build Back Better Act: “The legislation that passed the House today…
Learn more
Patients Empowered with New “Clinical Trials: The…
The Biotechnology Innovation Organization (BIO) today announced the launch of Clinical Trials: The Power of Participation (CTPoP), a website that addresses how clinical trials work, how to enroll in a clinical trial, and what to expect as a clinical…
Learn more
White House’s “Build Back Better” Plan Builds New…
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), made the following statement: "Last week, Democratic leaders announced they had reached a drug pricing “deal.” We wanted to see the details before…
Learn more
Letters, Testimony, & Comments
Browse All
BIO Comments on the Diverse and Equitable…
BIO is committed to enhancing clinical trial diversity as part of our BIOEquality Agenda published in the fall of 2020. During the pandemic we witnessed biopharmaceutical companies achieve increased clinical trial diversity through commitment and…
Learn more
BIO Comments on FDA Draft Guidance, Benefit-Risk…
On Monday, November 29th, BIO submitted comments in response to a recent FDA draft guidance for industry clarifying how considerations about a drug’s benefits, risks, and risk management options factor into certain premarket and postmarket…
Learn more
BIO Joins Letter to Congressional Leaders…
The undersigned organizations and institutions, representing hundreds of thousands of individuals and entities working in science, technology, engineering, medicine, and mathematics would like to call your attention to the recent reintroduction of…
Learn more
Amicus Briefs
Browse All
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
Learn more
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
Learn more
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Learn more
Blog Posts
Browse all Blogs
sustainable aviation fuels
World’s first passenger flight with 100% renewable fuel takes off—thanks to biotech
December 3, 2021
The first commercial passenger flight to use 100% sustainable aviation fuel (SAF) took off yesterday—possibly the biggest leap forward for modern aviation since the Wright brothers first flew the Wright Flyer nearly 118…
AMR
Antimicrobial Resistance: The Silent Pandemic
November 23, 2021
We are on the precipice of a looming crisis. Antimicrobial resistance (AMR) is the evolution of deadly pathogens like bacteria and fungi to resist all current antimicrobial medicines. In this episode, we talk about how…
carbon plants
Repurposing carbon shows promise as an important part of combatting climate change
November 18, 2021
Throughout COP26, the United Nation’s Climate Change Conference, in Glasgow, one word was at the heart of the debate over how policymakers must confront climate change: carbon. Reducing carbon emissions is essential to…